Mechanism of action on ocular structures
The action of ophthalmic muscarinic antagonists is based on the competitive blockade of corresponding receptors in the smooth muscle of the eye. This leads to two key pharmacodynamic effects:
- Mydriasis (pupillary dilation). Develops as a result of relaxation of the sphincter pupillae muscle.
- Cycloplegia (paralysis of accommodation). Occurs due to paralysis of the ciliary muscle, causing the lens to tighten and flatten, while the eye temporarily loses its ability to focus on close objects.
Both of these effects are critical for performing a comprehensive eye examination and determining the true optical parameters of the eye.
Tropicamide: standard for rapid diagnostics
Tropicamide (Mydriacyl) is one of the most sought-after medications due to its pharmacokinetics. Its key advantage lies in the extremely short duration of accommodation paralysis.
Key parameters of action:
- Onset of effect: very rapid, occurring within 5–10 minutes.
- Duration of cycloplegia: only 1–2 hours (with a peak at 20–40 minutes).
- Duration of mydriasis: persists for up to 6 hours.
Such a short duration profile makes tropicamide an ideal agent for routine fundus examination. The patient relatively quickly regains the ability to see normally after visiting the doctor.
Cyclopentolate and homatropine
In situations where a longer-lasting effect is required, other agents from this group are used:
- Cyclopentolate (Cyclomed). Produces effects similar to tropicamide (pronounced mydriasis and cycloplegia), but has a significantly longer duration of action—from 20 to 24 hours. This makes it the drug of choice for refraction testing in young children, as well as for various short-term diagnostic procedures.
- Homatropine. A synthetic substance (a tertiary amine, an ester of tropine and mandelic acid). In its pharmacological properties, it is very close to atropine, but differs in lower activity and a shortened duration of action—about 15–20 hours. In medical practice, it is used for pupillary dilation predominantly in the form of homatropine methylbromide.
Side effects and contraindications
Despite topical administration in the form of eye drops, these drugs can cause systemic side effects. This occurs due to their systemic absorption into the bloodstream through the mucous membrane of the nasolacrimal duct.
Typical systemic manifestations include:
- Headache;
- Tachycardia;
- Severe dry mouth;
- Photophobia due to the dilated pupil.
Special attention should be paid to pediatric practice: children have a high risk of developing hyperthermia when using these drugs.
Absolute contraindication! All muscarinic antagonists are strictly prohibited in glaucoma. The resulting mydriasis inevitably disrupts the outflow of fluid from the anterior chamber of the eye, which provokes a dangerous increase in intraocular pressure.
Briefly: answers to topical questions
Which receptors are blocked by muscarinic antagonists in the smooth muscle of the eye?
Muscarinic antagonists in ophthalmology exert their effects by blocking specific receptors in ocular structures. The target for these medications is $M_3$ muscarinic receptors.
- $M_3$ muscarinic receptors are the primary target blocked in the sphincter pupillae and the ciliary body.
As a result of blocking these receptors in the sphincter pupillae, the muscle relaxes and the pupil dilates, whereas blocking the receptors of the ciliary muscle leads to cycloplegia.
The abbreviation MC can help remember the main effects of the group: Mydriasis + Cycloplegia (wide pupil, lost focus).
Class and exam questions
Why is tropicamide more frequently used for fundus examination?
Its main advantage is the short duration of cycloplegia (only 1–2 hours). This allows for diagnostics while quickly restoring comfortable vision for the patient.
Which drug is best chosen for determining refraction in children?
In pediatric practice, cyclopentolate is frequently used. It provides stable mydriasis and cycloplegia lasting 20–24 hours, which is necessary for accurate measurement.
Where do tachycardia and dry mouth come from when instilling eye drops?
These systemic effects occur because the solution enters the nasolacrimal duct, from where it is absorbed directly into the bloodstream through the mucous membrane.
Why cannot muscarinic antagonists be used in glaucoma?
Pupillary dilation (mydriasis) caused by these drugs leads to thickening of the iris root. This mechanically impedes the outflow of aqueous humor and can cause a sharp increase in intraocular pressure.
What else to study on this topic
- Mechanism of systemic side effects via the nasolacrimal duct.
- Differences in duration of action: tropicamide, cyclopentolate, homatropine.
- Chemical structure of homatropine as a tertiary amine.
- Physiological basis of accommodation and the role of the ciliary muscle.
- Anatomy of intraocular fluid outflow and risks in glaucoma.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Muscarinic antagonists in ophthalmology" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section «Drugs acting on cholinergic synapses»
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.